We will be discussing what we must do to prevent us falling into the trap of simply swapping one health crisis for another.”

Ban katantaFinally, I will sign off by plagiarising myself from my most recent post. I want to assure you all that while many countries begin to experience worrisome new spikes of infection and a second wave of the pandemic looms large over parts of the world we recognise that cancer does not go into lockdown, but neither does our passion or commitment to addressing the needs of cancer patients. This is why I am so very proud of all the work that our Roche colleagues across the globe have been doing to continue to ensure progress is not brought to a standstill, and vitally that patients can still access the essential cancer diagnosis and medicines they need. To all my colleagues at Roche and those on the front line supporting cancer patients through these unprecedented times, I feel humbled and filled with gratitude because of your dedication to the cause, you are extraordinary and I thank you all.

Please stay safe and well, and remember that together we are stronger.


Learn about how advancements in research, diagnosis and treatments may transform the lives of people with cancer today and in the future:


  1. Pursuit - The University of Melbourne. Is a delayed cancer diagnosis a consequence of COVID-19? [Internet; cited August 2020]. Available from: .
  2. Maringe et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncology. 2020(21):1023-34.
  3. Kaufman H. et al. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) Pandemic. JAMA Network Open. 2020(3): pp.e2017267-e2017267.
  4. IBTA. COVID-19 alliance statement. [Internet; cited August 2020]. Available from: .

See below for examples of how we are accelerating progress in cancer care

Tags: Innovation, People, Patients, Science